logo

AHCO

AdaptHealth·NASDAQ
--
--(--)
--
--(--)
9.71 / 10
Outperform

Financial evaluation reveals an outstanding score of 9.7/10, driven by robust revenue and cash-flow growth. Key positives include high Revenue-MV (1.60) and Cash-MV (1.43) values, while challenges remain in Diluted EPS and Total Profit YoY growth. Overall, the company’s fundamental standing is excellent, supporting a long-term hold for patient investors.

Fundamental(9.71)SentimentTechnical

Analysis Checks(3/10)

Revenue-MV
Value1.60
Score2/3
Weight37.41%
1M Return2.24%
Net cash flow from operating activities per share (YoY growth rate %)
Value6.24
Score1/3
Weight10.18%
1M Return0.65%
Profit-MV
Value0.27
Score1/3
Weight10.67%
1M Return0.63%
Net income-Revenue
Value-1.35
Score1/3
Weight13.18%
1M Return0.88%
PB-ROE
Value-0.77
Score0/3
Weight-22.53%
1M Return-1.70%
Total profit (YoY growth rate %)
Value26.85
Score0/3
Weight-51.27%
1M Return-4.48%
Net cash flow from operating activities (YoY growth rate %)
Value6.94
Score2/3
Weight44.95%
1M Return2.69%
Cash-UP
Value-0.20
Score0/3
Weight-35.76%
1M Return-2.32%
Diluted earnings per share (YoY growth rate %)
Value-22.22
Score0/3
Weight-34.08%
1M Return-2.81%
Cash-MV
Value1.43
Score3/3
Weight127.24%
1M Return7.18%
Is AHCO fundamentally strong?
  • AHCO scores 9.71/10 on fundamentals and holds a Discounted valuation at present. Backed by its 1.83% ROE, 2.67% net margin, 17.38 P/E ratio, 0.89 P/B ratio, and 134.36% earnings growth, these metrics solidify its Outperform investment rating.